Stand with patients, doctors, and California’s innovative life sciences sector by telling Congress to reject H.R. 3, a flawed proposal that would bring foreign drug price controls to the U.S. and cripple innovation. The implementation of foreign price controls would reduce the number of innovative treatments and cures brought to American patients and eliminate over 190,000 biotech R&D jobs nationwide.
We can’t let that happen. Send a message to your Representative to make sure H.R. 3 does not pass.